Evidence map›Paper›PMID 31487817›Full record

ArticleInternational journal of molecular sciences2019

Multi-Staged Regulation of Lipid Signaling Mediators during Myogenesis by COX-1/2 Pathways.

Chenglin Mo, Zhiying Wang, Lynda Bonewald, Marco Brotto

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Numb is required for optimal contraction of skeletal muscle.Journal of cachexia, sarcopenia and muscle · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chenglin MoBone-Muscle Research Center, College of Nursing and Health Innovation, The University of Texas-Arlington, Arlington, TX 76019, USA. chenglin.mo@uta.edu.
Zhiying WangBone-Muscle Research Center, College of Nursing and Health Innovation, The University of Texas-Arlington, Arlington, TX 76019, USA. zhiying.wang@uta.edu.ORCID 0000-0003-0358-6337
Lynda BonewaldIndiana Center for Musculoskeletal Health, School of Medicine, Indiana University, Indianapolis, IN 46202, USA. lbonewal@iu.edu.ORCID 0000-0002-5536-9943
Marco BrottoBone-Muscle Research Center, College of Nursing and Health Innovation, The University of Texas-Arlington, Arlington, TX 76019, USA. marco.brotto@uta.edu.
The University of Texas at Arlington · USIndiana University – Purdue University Indianapolis · US

Funding

NIH HHS PO1 AG039355University of Texas-Arlington George W. and Hazel M. Jay Endowment
6 · The paper itself

Abstract

Cyclooxygenases (COXs), including COX-1 and -2, are enzymes essential for lipid mediator (LMs) syntheses from arachidonic acid (AA), such as prostaglandins (PGs). Furthermore, COXs could interplay with other enzymes such as lipoxygenases (LOXs) and cytochrome P450s (CYPs) to regulate the signaling of LMs. In this study, to comprehensively analyze the function of COX-1 and -2 in regulating the signaling of bioactive LMs in skeletal muscle, mouse primary myoblasts and C2C12 cells were transfected with specific COX-1 and -2 siRNAs, followed by targeted lipidomic analysis and customized quantitative PCR gene array analysis. Knocking down COXs, particularly COX-1, significantly reduced the release of PGs from muscle cells, especially PGE

Indexed as

Muscle DevelopmentSignal TransductionAnimalsCell LineCells, CulturedCyclooxygenase 1Cyclooxygenase 2DinoprostoneInositol 1,4,5-Trisphosphate ReceptorsLipoxygenaseMiceMice, Inbred C57BLMyoblasts, SkeletalMyosin Heavy ChainsCyclooxygenase 1Cyclooxygenase 2DinoprostoneInositol 1,4,5-Trisphosphate ReceptorsItpr1 protein, mouseLipoxygenaseMyh7 protein, mouseMyosin Heavy ChainsCyclooxygenaselipidomicsmyogenic differentiationskeletal muscle

Identifiers

PMID31487817
PMCPMC6769623
OpenAlexW2971408418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.